HHC Stock Overview
H+H International A/S provides wall building materials and solutions in the United Kingdom, Central Western Europe, and Poland.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
H+H International A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr.105.60 |
52 Week High | kr.187.00 |
52 Week Low | kr.105.60 |
Beta | 1.34 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -43.16% |
3 Year Change | 34.35% |
5 Year Change | -17.24% |
Change since IPO | 132.86% |
Recent News & Updates
Recent updates
Shareholder Returns
HHC | GB Basic Materials | GB Market | |
---|---|---|---|
7D | 0% | 3.8% | 1.3% |
1Y | -43.2% | 12.0% | 3.5% |
Return vs Industry: HHC underperformed the UK Basic Materials industry which returned 3.2% over the past year.
Return vs Market: HHC underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
HHC volatility | |
---|---|
HHC Average Weekly Movement | n/a |
Basic Materials Industry Average Movement | 3.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HHC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HHC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 1,739 | Jorg Brinkmann | www.hplush.com |
H+H International A/S produces and sells autoclaved aerated concrete and calcium silicate building blocks used for wall-building and pre-cast wall-panel solutions in the United Kingdom, Central Western Europe, and Poland. It offers elements and partition walls; foundation blocks; high-insulating blocks; and a range of traded goods. The company’s products are used primarily in the residential new building segment.
H+H International A/S Fundamentals Summary
HHC fundamental statistics | |
---|---|
Market cap | kr.1.78b |
Earnings (TTM) | kr.303.00m |
Revenue (TTM) | kr.3.60b |
5.9x
P/E Ratio0.5x
P/S RatioIs HHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HHC income statement (TTM) | |
---|---|
Revenue | kr.3.60b |
Cost of Revenue | kr.2.58b |
Gross Profit | kr.1.02b |
Other Expenses | kr.717.00m |
Earnings | kr.303.00m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 10, 2023
Earnings per share (EPS) | 18.61 |
Gross Margin | 28.30% |
Net Profit Margin | 8.41% |
Debt/Equity Ratio | 47.5% |
How did HHC perform over the long term?
See historical performance and comparison